Intravenous Ketamine for Treatment-Resistant Depression

Clinical trial NCT06668571 · RECRUITING

Trial details

NCT number: NCT06668571
Sponsor: Mayo Clinic
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Depressive Disorder, Treatment-Resistant Treatment Resistant Depression (TRD)

Start date: 2025-02-10
Primary completion: 2027-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.